{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:18:54Z","timestamp":1789417134514,"version":"build-2803163510"},"reference-count":282,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Neurodegenerative diseases (NDs), like amyotrophic lateral sclerosis (ALS), Alzheimer\u2019s disease (AD), and Parkinson\u2019s disease (PD), primarily affect the central nervous system, leading to progressive neuronal loss and motor and cognitive dysfunction. However, recent studies have revealed that muscle tissue also plays a significant role in these diseases. ALS is characterized by severe muscle wasting as a result of motor neuron degeneration, as well as alterations in gene expression, protein aggregation, and oxidative stress. Muscle atrophy and mitochondrial dysfunction are also observed in AD, which may exacerbate cognitive decline due to systemic metabolic dysregulation. PD patients exhibit muscle fiber atrophy, altered muscle composition, and \u03b1-synuclein aggregation within muscle cells, contributing to motor symptoms and disease progression. Systemic inflammation and impaired protein degradation pathways are common among these disorders, highlighting muscle tissue as a key player in disease progression. Understanding these muscle-related changes offers potential therapeutic avenues, such as targeting mitochondrial function, reducing inflammation, and promoting muscle regeneration with exercise and pharmacological interventions. This review emphasizes the importance of considering an integrative approach to neurodegenerative disease research, considering both central and peripheral pathological mechanisms, in order to develop more effective treatments and improve patient outcomes.<\/jats:p>","DOI":"10.3390\/biology13090719","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T10:15:27Z","timestamp":1726136127000},"page":"719","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["From Brain to Muscle: The Role of Muscle Tissue in Neurodegenerative Disorders"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0631-3676","authenticated-orcid":false,"given":"Elisa","family":"Duranti","sequence":"first","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2730-5974","authenticated-orcid":false,"given":"Chiara","family":"Villa","sequence":"additional","affiliation":[{"name":"School of Medicine and Surgery, University of Milano-Bicocca, 20900 Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Dugger, B.N., and Dickson, D.W. (2017). Pathology of Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol., 9.","DOI":"10.1101\/cshperspect.a028035"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Villa, C., Paudel, Y.N., and Piperi, C. (2022). New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders. Brain Sci., 12.","DOI":"10.3390\/books978-3-0365-5485-3"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Duranti, E., and Villa, C. (2022). Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010704"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Duranti, E., and Villa, C. (2023). Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics. Biomolecules, 13.","DOI":"10.3390\/biom13111582"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Bastin, C., Giacomelli, F., Mi\u00e9vis, F., Lemaire, C., Guillaume, B., and Salmon, E. (2021). Anosognosia in Mild Cognitive Impairment: Lack of Awareness of Memory Difficulties Characterizes Prodromal Alzheimer\u2019s Disease. Front. Psychiatry, 12.","DOI":"10.3389\/fpsyt.2021.631518"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"V\u00e1radi, C. (2020). Clinical Features of Parkinson\u2019s Disease: The Evolution of Critical Symptoms. Biology, 9.","DOI":"10.3390\/biology9050103"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.7150\/thno.83066","article-title":"New strategies of neurodegenerative disease treatment with extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs)","volume":"13","author":"Palanisamy","year":"2023","journal-title":"Theranostics"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease: Models, mechanisms, and a new hope","volume":"10","author":"Gitler","year":"2017","journal-title":"Dis. Model Mech."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-cellbio-040320-120625","article-title":"Developing Therapies for Neurodegenerative Disorders: Insights from Protein Aggregation and Cellular Stress Responses","volume":"36","author":"Mallucci","year":"2020","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Schaffert, L.N., and Carter, W.G. (2020). Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review. Brain Sci., 10.","DOI":"10.3390\/brainsci10040232"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Candelise, N., Scaricamazza, S., Salvatori, I., Ferri, A., Valle, C., Manganelli, V., Garofalo, T., Sorice, M., and Misasi, R. (2021). Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22116016"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Duranti, E., and Villa, C. (2024). Insights into Dysregulated Neurological Biomarkers in Cancer. Cancers, 16.","DOI":"10.3390\/cancers16152680"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41582-020-0377-8","article-title":"Applications of machine learning to diagnosis and treatment of neurodegenerative diseases","volume":"16","author":"Myszczynska","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Dur\u00e3es, F., Pinto, M., and Sousa, E. (2018). Old Drugs as New Treatments for Neurodegenerative Diseases. Pharmaceuticals, 11.","DOI":"10.3390\/ph11020044"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Burtscher, J., Millet, G.P., Place, N., Kayser, B., and Zanou, N. (2021). The Muscle-Brain Axis and Neurodegenerative Diseases: The Key Role of Mitochondria in Exercise-Induced Neuroprotection. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126479"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bian, X., Wang, Q., Wang, Y., and Lou, S. (2023). The function of previously unappreciated exerkines secreted by muscle in regulation of neurodegenerative diseases. Front. Mol. Neurosci., 16.","DOI":"10.3389\/fnmol.2023.1305208"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1093\/brain\/awad202","article-title":"Skeletal muscle in amyotrophic lateral sclerosis","volume":"146","author":"Shefner","year":"2023","journal-title":"Brain"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1111\/jgs.17206","article-title":"Sarcopenia is associated with incident Alzheimer\u2019s dementia, mild cognitive impairment, and cognitive decline","volume":"69","author":"Beeri","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Raleigh, S.M., and Orchard, K.J.A. (2024). Sarcopenia as a Risk Factor for Alzheimer\u2019s Disease: Genetic and Epigenetic Perspectives. Genes, 15.","DOI":"10.3390\/genes15050561"},{"key":"ref_21","first-page":"679","article-title":"Parkinson Disease","volume":"102","author":"Luker","year":"2020","journal-title":"Am. Fam. Physician"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ferreira-S\u00e1nchez, M.D.R., Moreno-Verd\u00fa, M., and Cano-de-la-Cuerda, R. (2020). Quantitative Measurement of Rigidity in Parkinson\u2019s Disease: A Systematic Review. Sensors, 20.","DOI":"10.3390\/s20030880"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/CIA.S6920","article-title":"Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: An update","volume":"5","author":"Waters","year":"2010","journal-title":"Clin. Interv. Aging"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s10529-020-02886-1","article-title":"Therapeutic potential of stem cells for treatment of neurodegenerative diseases","volume":"42","author":"Zarrindast","year":"2020","journal-title":"Biotechnol. Lett."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/cns.12655","article-title":"Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment","volume":"23","author":"Golpich","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00223-014-9915-y","article-title":"Skeletal muscle: A brief review of structure and function","volume":"96","author":"Frontera","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Vainshtein, A., and Sandri, M. (2020). Signaling Pathways That Control Muscle Mass. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134759"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00424-018-2217-x","article-title":"Exercise and the control of muscle mass in human","volume":"471","author":"Francaux","year":"2019","journal-title":"Pflug. Arch."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00003677-200307000-00005","article-title":"Contractile and nutritional regulation of human muscle growth","volume":"31","author":"Rasmussen","year":"2003","journal-title":"Exerc. Sport. Sci. Rev."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1016\/j.yexcr.2010.05.019","article-title":"Skeletal muscle: Energy metabolism, fiber types, fatigue and adaptability","volume":"316","author":"Westerblad","year":"2010","journal-title":"Exp. Cell Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0026-0495(94)90081-7","article-title":"Whole-body energy metabolism and skeletal muscle biochemical characteristics","volume":"43","author":"Zurlo","year":"1994","journal-title":"Metabolism"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kamei, Y., Hatazawa, Y., Uchitomi, R., Yoshimura, R., and Miura, S. (2020). Regulation of Skeletal Muscle Function by Amino Acids. Nutrients, 12.","DOI":"10.3390\/nu12010261"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/jb\/mvy019","article-title":"The roles of muscle stem cells in muscle injury, atrophy and hypertrophy","volume":"163","author":"Fukada","year":"2018","journal-title":"J. Biochem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Duranti, E., and Villa, C. (2023). Influence of DUX4 Expression in Facioscapulohumeral Muscular Dystrophy and Possible Treatments. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119503"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"dmm042192","DOI":"10.1242\/dmm.042192","article-title":"Skeletal muscle in health and disease","volume":"13","author":"Morgan","year":"2020","journal-title":"Dis. Models Mech."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shirakawa, T., Toyono, T., Inoue, A., Matsubara, T., Kawamoto, T., and Kokabu, S. (2022). Factors Regulating or Regulated by Myogenic Regulatory Factors in Skeletal Muscle Stem Cells. Cells, 11.","DOI":"10.3390\/cells11091493"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcdb.2017.11.011","article-title":"Function of the myogenic regulatory factors Myf5, MyoD, Myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis","volume":"72","author":"Zammit","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-981-13-1435-3_2","article-title":"Myofibers","volume":"1088","author":"Cretoiu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mukund, K., and Subramaniam, S. (2020). Skeletal muscle: A review of molecular structure and function, in health and disease. Wiley Interdiscip. Rev. Syst. Biol. Med., 12.","DOI":"10.1002\/wsbm.1462"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Wang, H., Guan, L., and Deng, M. (2023). Recent progress of the genetics of amyotrophic lateral sclerosis and challenges of gene therapy. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1170996"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-023-00685-6","article-title":"Fluid biomarkers for amyotrophic lateral sclerosis: A review","volume":"19","author":"Irwin","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1007\/s10072-024-07508-6","article-title":"Skeletal muscle dysfunction in amyotrophic lateral sclerosis: A mitochondrial perspective and therapeutic approaches","volume":"45","author":"Kubat","year":"2024","journal-title":"Neurol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(07)60944-1","article-title":"Amyotrophic lateral sclerosis","volume":"369","author":"Mitchell","year":"2007","journal-title":"Lancet"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nn.3584","article-title":"State of play in amyotrophic lateral sclerosis genetics","volume":"17","author":"Renton","year":"2014","journal-title":"Nat. Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., and Patel, B.K. (2019). Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis. Front. Mol. Neurosci., 12.","DOI":"10.3389\/fnmol.2019.00025"},{"key":"ref_46","first-page":"5021694","article-title":"Oxidative Stress in Amyotrophic Lateral Sclerosis: Pathophysiology and Opportunities for Pharmacological Intervention","volume":"2020","author":"Montezinho","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Motataianu, A., Serban, G., Barcutean, L., and Balasa, R. (2022). Oxidative Stress in Amyotrophic Lateral Sclerosis: Synergy of Genetic and Environmental Factors. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169339"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Huai, J., and Zhang, Z. (2019). Structural Properties and Interaction Partners of Familial ALS-Associated SOD1 Mutants. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00527"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in ALS","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"132933","DOI":"10.1016\/j.neulet.2017.06.052","article-title":"The role of mitochondria in amyotrophic lateral sclerosis","volume":"710","author":"Smith","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","article-title":"The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis","volume":"1762","author":"Bogaert","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Arnold, F.J., Putka, A.F., Raychaudhuri, U., Hsu, S., Bedlack, R.S., Bennett, C.L., and La Spada, A.R. (2024). Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25115587"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Li, Q., and Haney, M.S. (2020). The role of glia in protein aggregation. Neurobiol. Dis., 143.","DOI":"10.1016\/j.nbd.2020.105015"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Liu, J., and Wang, F. (2017). Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.01005"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Castellanos-Montiel, M.J., Chaineau, M., and Durcan, T.M. (2020). The Neglected Genes of ALS: Cytoskeletal Dynamics Impact Synaptic Degeneration in ALS. Front. Cell. Neurosci., 14.","DOI":"10.3389\/fncel.2020.594975"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bpa.12350","article-title":"The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis","volume":"26","author":"Loeffler","year":"2016","journal-title":"Brain Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Pikatza-Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz-Gastesi, N., L\u00f3pez de Munain, A., Gerenu, G., Gil-Bea, F.J., and Alonso-Mart\u00edn, S. (2021). The Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070671"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Biedasek, K., Andres, J., Mai, K., Adams, S., Spuler, S., Fielitz, J., and Spranger, J. (2011). Skeletal muscle 11beta-HSD1 controls glucocorticoid-induced proteolysis and expression of E3 ubiquitin ligases atrogin-1 and MuRF-1. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016674"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s40478-014-0165-z","article-title":"Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study","volume":"2","author":"King","year":"2014","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuint.2014.10.007","article-title":"ALS-related misfolded protein management in motor neurons and muscle cells","volume":"79","author":"Galbiati","year":"2014","journal-title":"Neurochem. Int."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Vicencio, E., Beltr\u00e1n, S., Labrador, L., Manque, P., Nassif, M., and Woehlbier, U. (2020). Implications of Selective Autophagy Dysfunction for ALS Pathology. Cells, 9.","DOI":"10.3390\/cells9020381"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-031-38215-4_5","article-title":"Upper and Lower Motor Neurons and the Skeletal Muscle: Implication for Amyotrophic Lateral Sclerosis (ALS)","volume":"Volume 236","author":"Kablar","year":"2023","journal-title":"Roles of Skeletal Muscle in Organ Development\u2014Prenatal Interdependence among Cells, Tissues, and Organs"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Amin, A., Perera, N.D., Beart, P.M., Turner, B.J., and Shabanpoor, F. (2020). Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting. Cells, 9.","DOI":"10.3390\/cells9112413"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The role of autophagy in neurodegenerative disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.neuron.2022.01.017","article-title":"The different autophagy degradation pathways and neurodegeneration","volume":"110","author":"Fleming","year":"2022","journal-title":"Neuron"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mus.1114","article-title":"Cell death and apoptosis-related proteins in muscle biopsies of sporadic amyotrophic lateral sclerosis and polyneuropathy","volume":"24","author":"Schoser","year":"2001","journal-title":"Muscle Nerve"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/bph.15276","article-title":"What skeletal muscle has to say in amyotrophic lateral sclerosis: Implications for therapy","volume":"178","author":"Manzano","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e12271","DOI":"10.14814\/phy2.12271","article-title":"Suppressed autophagy flux in skeletal muscle of an amyotrophic lateral sclerosis mouse model during disease progression","volume":"3","author":"Xiao","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"147904","DOI":"10.1016\/j.brainres.2022.147904","article-title":"The pathogenesis of amyotrophic lateral sclerosis: Mitochondrial dysfunction, protein misfolding and epigenetics","volume":"1786","author":"Chen","year":"2022","journal-title":"Brain Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mus.27444","article-title":"Reinnervation as measured by the motor unit size index is associated with preservation of muscle strength in amyotrophic lateral sclerosis, but not all muscles reinnervate","volume":"65","author":"Chan","year":"2022","journal-title":"Muscle Nerve"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/mus.27413","article-title":"Alterations in fast-twitch muscle membrane conductance regulation do not explain decreased muscle function of SOD1(G93A) rats","volume":"64","author":"Leermakers","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Quessada, C., Bouscary, A., Ren\u00e9, F., Valle, C., Ferri, A., Ngo, S.T., and Loeffler, J.P. (2021). Skeletal Muscle Metabolism: Origin or Prognostic Factor for Amyotrophic Lateral Sclerosis (ALS) Development?. Cells, 10.","DOI":"10.3390\/cells10061449"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Anderson, G. (2022). Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24010587"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Peggion, C., Scalcon, V., Massimino, M.L., Nies, K., Lopreiato, R., Rigobello, M.P., and Bertoli, A. (2022). SOD1 in ALS: Taking Stock in Pathogenic Mechanisms and the Role of Glial and Muscle Cells. Antioxidants, 11.","DOI":"10.3390\/antiox11040614"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.coph.2009.03.007","article-title":"Neuromuscular junction destruction during amyotrophic lateral sclerosis: Insights from transgenic models","volume":"9","author":"Dupuis","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e14012","DOI":"10.1111\/apha.14012","article-title":"Slow or fast: Implications of myofibre type and associated differences for manifestation of neuromuscular disorders","volume":"238","author":"Lloyd","year":"2023","journal-title":"Acta Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","article-title":"Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis","volume":"133","author":"Nijssen","year":"2017","journal-title":"Acta Neuropathol."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Venditti, P., and Di Meo, S. (2020). The Role of Reactive Oxygen Species in the Life Cycle of the Mitochondrion. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21062173"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Pollari, E., Goldsteins, G., Bart, G., Koistinaho, J., and Giniatullin, R. (2014). The role of oxidative stress in degeneration of the neuromuscular junction in amyotrophic lateral sclerosis. Front. Cell. Neurosci., 8.","DOI":"10.3389\/fncel.2014.00131"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/NXI.0000000000000244","article-title":"Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis","volume":"3","author":"Lu","year":"2016","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/156652411795243450","article-title":"The Role of immune and inflammatory mechanisms in ALS","volume":"11","author":"McCombe","year":"2011","journal-title":"Curr. Mol. Med."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Jensen, L., J\u00f8rgensen, L.H., Bech, R.D., Frandsen, U., and Schr\u00f8der, H.D. (2016). Skeletal Muscle Remodelling as a Function of Disease Progression in Amyotrophic Lateral Sclerosis. Biomed. Res. Int., 2016.","DOI":"10.1155\/2016\/5930621"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/bs.ctdb.2017.08.005","article-title":"The Composition, Development, and Regeneration of Neuromuscular Junctions","volume":"126","author":"Liu","year":"2018","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e41973","DOI":"10.7554\/eLife.41973","article-title":"Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS","volume":"7","author":"Martineau","year":"2018","journal-title":"eLife"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12031-010-9467-1","article-title":"The \u201cdying-back\u201d phenomenon of motor neurons in ALS","volume":"43","author":"Melamed","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Lepore, E., Casola, I., Dobrowolny, G., and Musar\u00f2, A. (2019). Neuromuscular Junction as an Entity of Nerve-Muscle Communication. Cells, 8.","DOI":"10.3390\/cells8080906"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1242\/dev.005934","article-title":"Satellite and stem cells in muscle growth and repair","volume":"134","author":"Rudnicki","year":"2007","journal-title":"Development"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.37765\/ajmc.2023.89389","article-title":"Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life","volume":"29","author":"Lynch","year":"2023","journal-title":"Am. J. Manag. Care"},{"key":"ref_89","first-page":"61","article-title":"Riluzole: Real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosis","volume":"7","author":"Hinchcliffe","year":"2017","journal-title":"Degener. Neurol. Neuromuscul. Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/ene.14393","article-title":"Amyotrophic lateral sclerosis: A clinical review","volume":"27","author":"Masrori","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.3390\/molecules20057775","article-title":"Riluzole as a neuroprotective drug for spinal cord injury: From bench to bedside","volume":"20","author":"Nagoshi","year":"2015","journal-title":"Molecules"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1046\/j.1471-4159.2000.0752259.x","article-title":"Protective effects of riluzole on dopamine neurons: Involvement of oxidative stress and cellular energy metabolism","volume":"75","author":"Storch","year":"2000","journal-title":"J. Neurochem."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Duranti, E., Cordani, N., and Villa, C. (2024). Edaravone: A Novel Possible Drug for Cancer Treatment?. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031633"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Cha, S.J., and Kim, K. (2022). Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection. Antioxidants, 11.","DOI":"10.3390\/antiox11020195"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Mor\u00e9n, C., deSouza, R.M., Giraldo, D.M., and Uff, C. (2022). Antioxidant Therapeutic Strategies in Neurodegenerative Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23169328"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0006-8993(97)00490-3","article-title":"Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia","volume":"762","author":"Yamamoto","year":"1997","journal-title":"Brain Res."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Tzeplaeff, L., Wilfling, S., Requardt, M.V., and Herdick, M. (2023). Current State and Future Directions in the Therapy of ALS. Cells, 12.","DOI":"10.3390\/cells12111523"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jiang, J., Wang, Y., and Deng, M. (2022). New developments and opportunities in drugs being trialed for amyotrophic lateral sclerosis from 2020 to 2022. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1054006"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40035-022-00307-z","article-title":"Tauroursodeoxycholic acid: A potential therapeutic tool in neurodegenerative diseases","volume":"11","author":"Khalaf","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s40265-022-01769-1","article-title":"Pharmacotherapy for Amyotrophic Lateral Sclerosis: A Review of Approved and Upcoming Agents","volume":"82","author":"Johnson","year":"2022","journal-title":"Drugs"},{"key":"ref_101","first-page":"216","article-title":"The effectiveness and value of AMX0035 and oral edaravone for amyotrophic lateral sclerosis: A summary from the Institute for Clinical and Economic Review\u2019s Midwest Comparative Effectiveness Public Advisory Council","volume":"29","author":"Nikitin","year":"2023","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mus.27091","article-title":"Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis","volume":"63","author":"Paganoni","year":"2021","journal-title":"Muscle Nerve"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/14737175.2024.2355983","article-title":"Profiling tofersen as a treatment of superoxide dismutase 1 amyotrophic lateral sclerosis","volume":"24","year":"2024","journal-title":"Expert. Rev. Neurother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e16140","DOI":"10.1111\/ene.16140","article-title":"Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis","volume":"31","author":"Saini","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11357-018-0020-4","article-title":"Exercise attenuates age-associated changes in motoneuron number, nucleocytoplasmic transport proteins and neuromuscular health","volume":"40","author":"Gillon","year":"2018","journal-title":"Geroscience"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1113\/JP271212","article-title":"The ageing neuromuscular system and sarcopenia: A mitochondrial perspective","volume":"594","author":"Rygiel","year":"2016","journal-title":"J. Physiol."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Ferri, E., Marzetti, E., Calvani, R., Picca, A., Cesari, M., and Arosio, B. (2020). Role of Age-Related Mitochondrial Dysfunction in Sarcopenia. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21155236"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Sailani, M.R., Halling, J.F., M\u00f8ller, H.D., Lee, H., Plomgaard, P., Pilegaard, H., Snyder, M.P., and Regenberg, B. (2019). Lifelong physical activity is associated with promoter hypomethylation of genes involved in metabolism, myogenesis, contractile properties and oxidative stress resistance in aged human skeletal muscle. Sci. Rep., 9.","DOI":"10.1038\/s41598-018-37895-8"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10654-016-0119-9","article-title":"Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study","volume":"31","author":"Gallo","year":"2016","journal-title":"Eur. J. Epidemiol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.brainres.2009.11.051","article-title":"Moderate exercise delays the motor performance decline in a transgenic model of ALS","volume":"1313","author":"Carreras","year":"2010","journal-title":"Brain Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/stem.2957","article-title":"Markers of Accelerated Skeletal Muscle Regenerative Response in Murphy Roths Large Mice: Characteristics of Muscle Progenitor Cells and Circulating Factors","volume":"37","author":"Tseng","year":"2019","journal-title":"Stem Cells"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Bennett, E.J., Mead, R.J., Azzouz, M., Shaw, P.J., and Grierson, A.J. (2014). Early detection of motor dysfunction in the SOD1G93A mouse model of Amyotrophic Lateral Sclerosis (ALS) using home cage running wheels. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0107918"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Pradhan, J., Noakes, P.G., and Bellingham, M.C. (2019). The Role of Altered BDNF\/TrkB Signaling in Amyotrophic Lateral Sclerosis. Front. Cell. Neurosci., 13.","DOI":"10.3389\/fncel.2019.00368"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Wu, Y., Rakotoarisoa, M., Angelov, B., Deng, Y., and Angelova, A. (2022). Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery. Nanomaterials, 12.","DOI":"10.3390\/nano12132267"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Park, D., Kwak, S.G., Park, J.S., Choo, Y.J., and Chang, M.C. (2020). Can Therapeutic Exercise Slow Down Progressive Functional Decline in Patients With Amyotrophic Lateral Sclerosis? A Meta-Analysis. Front. Neurol., 11.","DOI":"10.3389\/fneur.2020.00853"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Musar\u00f2, A., Dobrowolny, G., Cambieri, C., Onesti, E., Ceccanti, M., Frasca, V., Pisano, A., Cerbelli, B., Lepore, E., and Ruffolo, G. (2019). Neuromuscular magnetic stimulation counteracts muscle decline in ALS patients: Results of a randomized, double-blind, controlled study. Sci. Rep., 9.","DOI":"10.1038\/s41598-019-39313-z"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","article-title":"Alzheimer\u2019s disease prevention: From risk factors to early intervention","volume":"9","author":"Gramunt","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuropharm.2013.07.004","article-title":"Therapeutics of Alzheimer\u2019s disease: Past, present and future","volume":"76 Pt A","author":"Anand","year":"2014","journal-title":"Neuropharmacology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Villa, C. (2020). Biomarkers for Alzheimer\u2019s Disease: Where Do We Stand and Where Are We Going?. J. Pers. Med., 10.","DOI":"10.3390\/jpm10040238"},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V., Kaur, R., and Singh, G. (2023). An Insight into Cellular and Molecular Mechanisms Underlying the Pathogenesis of Neurodegeneration in Alzheimer\u2019s Disease. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051398"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"D\u2019Argenio, V., and Sarnataro, D. (2020). New Insights into the Molecular Bases of Familial Alzheimer\u2019s Disease. J. Pers. Med., 10.","DOI":"10.3390\/jpm10020026"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/WNL.0000000000000596","article-title":"Symptom onset in autosomal dominant Alzheimer disease: A systematic review and meta-analysis","volume":"83","author":"Ryman","year":"2014","journal-title":"Neurology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0006-8993(93)90021-E","article-title":"Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease","volume":"623","author":"Kawai","year":"1993","journal-title":"Brain Res."},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Ogawa, Y., Kaneko, Y., Sato, T., Shimizu, S., Kanetaka, H., and Hanyu, H. (2018). Sarcopenia and Muscle Functions at Various Stages of Alzheimer Disease. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00710"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/archneurol.2009.240","article-title":"Association of muscle strength with the risk of Alzheimer disease and the rate of cognitive decline in community-dwelling older persons","volume":"66","author":"Boyle","year":"2009","journal-title":"Arch. Neurol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-220700","article-title":"Oxidative Stress and Natural Antioxidants: Back and Forth in the Neurological Mechanisms of Alzheimer\u2019s Disease","volume":"96","author":"Mani","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Misrani, A., Tabassum, S., and Yang, L. (2021). Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"780179","DOI":"10.1155\/2014\/780179","article-title":"Mitochondrial dysfunction: Different routes to Alzheimer\u2019s disease therapy","volume":"2014","author":"Picone","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Bell, S.M., Barnes, K., De Marco, M., Shaw, P.J., Ferraiuolo, L., Blackburn, D.J., Venneri, A., and Mortiboys, H. (2021). Mitochondrial Dysfunction in Alzheimer\u2019s Disease: A Biomarker of the Future?. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010063"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1002\/alz.13388","article-title":"Skeletal muscle mitochondrial function predicts cognitive impairment and is associated with biomarkers of Alzheimer\u2019s disease and neurodegeneration","volume":"19","author":"Tian","year":"2023","journal-title":"Alzheimers Dement."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.lfs.2017.07.012","article-title":"Effects of Huperzin-A on the Beta-amyloid accumulation in the brain and skeletal muscle cells of a rat model for Alzheimer\u2019s disease","volume":"184","author":"Turkseven","year":"2017","journal-title":"Life Sci."},{"key":"ref_135","first-page":"249","article-title":"Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer\u2019s disease. An immunoelectron microscopic study","volume":"141","author":"Yamaguchi","year":"1992","journal-title":"Am. J. Pathol."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Sehar, U., Rawat, P., Reddy, A.P., Kopel, J., and Reddy, P.H. (2022). Amyloid Beta in Aging and Alzheimer\u2019s Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112924"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","article-title":"Neuroinflammation in Alzheimer\u2019s Disease: Current Progress in Molecular Signaling and Therapeutics","volume":"46","author":"Thakur","year":"2023","journal-title":"Inflammation"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/gt.2010.124","article-title":"Skeletal muscle cells: From local inflammatory response to active immunity","volume":"18","author":"Marino","year":"2011","journal-title":"Gene Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/gerona\/glac121","article-title":"Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function","volume":"77","author":"Oudbier","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20743","article-title":"Oxidative stress, chronic disease, and muscle wasting","volume":"35","author":"Moylan","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"S\u0119dzikowska, A., and Szablewski, L. (2021). Insulin and Insulin Resistance in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22189987"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"104707","DOI":"10.1016\/j.neuint.2020.104707","article-title":"Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer\u2019s disease","volume":"135","author":"Akhtar","year":"2020","journal-title":"Neurochem. Int."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/j.1582-4934.2011.01318.x","article-title":"Possible implications of insulin resistance and glucose metabolism in Alzheimer\u2019s disease pathogenesis","volume":"15","author":"Bosco","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2022.09.032","article-title":"Altered glucose metabolism in Alzheimer\u2019s disease: Role of mitochondrial dysfunction and oxidative stress","volume":"193","author":"Dewanjee","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Ezkurdia, A., Ram\u00edrez, M.J., and Solas, M. (2023). Metabolic Syndrome as a Risk Factor for Alzheimer\u2019s Disease: A Focus on Insulin Resistance. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054354"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Arosio, B., Calvani, R., Ferri, E., Coelho-Junior, H.J., Carandina, A., Campanelli, F., Ghiglieri, V., Marzetti, E., and Picca, A. (2023). Sarcopenia and Cognitive Decline in Older Adults: Targeting the Muscle-Brain Axis. Nutrients, 15.","DOI":"10.3390\/nu15081853"},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Filardi, M., Barone, R., Bramato, G., Nigro, S., Tafuri, B., Frisullo, M.E., Zecca, C., Tortelli, R., and Logroscino, G. (2022). The Relationship between Muscle Strength and Cognitive Performance across Alzheimer\u2019s Disease Clinical Continuum. Front. Neurol., 13.","DOI":"10.3389\/fneur.2022.833087"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2174\/1567205013666160211124828","article-title":"Prevalence and associated factors of sarcopenia in elderly subjects with amnestic mild cognitive impairment or Alzheimer disease","volume":"13","author":"Sugimoto","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.nbd.2010.05.018","article-title":"Effects of nonsteroidal anti-inflammatory drugs on amyloid-beta pathology in mouse skeletal muscle","volume":"39","author":"Beckett","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exger.2018.10.011","article-title":"Impact of drugs with anti-inflammatory effects on skeletal muscle and inflammation: A systematic literature review","volume":"114","author":"Alturki","year":"2018","journal-title":"Exp. Gerontol."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Mantle, D., Heaton, R.A., and Hargreaves, I.P. (2021). Coenzyme Q10, Ageing and the Nervous System: An Overview. Antioxidants, 11.","DOI":"10.3390\/antiox11010002"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Gutierrez-Mariscal, F.M., Arenas-de Larriva, A.P., Limia-Perez, L., Romero-Cabrera, J.L., Yubero-Serrano, E.M., and L\u00f3pez-Miranda, J. (2020). Coenzyme Q(10) Supplementation for the Reduction of Oxidative Stress: Clinical Implications in the Treatment of Chronic Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21217870"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Vints, W.A.J., Levin, O., van Griensven, M., Vlaeyen, J.W.S., Masiulis, N., Verbunt, J., and van Laake-Geelen, C.C.M. (2024). Neuromuscular electrical stimulation to combat cognitive aging in people with spinal cord injury: Protocol for a single case experimental design study. BMC Neurol., 24.","DOI":"10.1186\/s12883-024-03699-9"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Ahmad, S.S., Ahmad, K., Lee, E.J., Lee, Y.H., and Choi, I. (2020). Implications of Insulin-Like Growth Factor-1 in Skeletal Muscle and Various Diseases. Cells, 9.","DOI":"10.3390\/cells9081773"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2174\/18715273113126660141","article-title":"The role of neuronal insulin\/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer\u2019s disease: Possible therapeutic implications","volume":"13","author":"Zemva","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000105156","article-title":"Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches","volume":"4","year":"2007","journal-title":"Neurodegener. Dis."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Franco-Bocanegra, D.K., McAuley, C., Nicoll, J.A.R., and Boche, D. (2019). Molecular Mechanisms of Microglial Motility: Changes in Ageing and Alzheimer\u2019s Disease. Cells, 8.","DOI":"10.3390\/cells8060639"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3233\/JAD-190863","article-title":"Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer\u2019s Disease","volume":"72","author":"Cioffi","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"111171","DOI":"10.1016\/j.exger.2020.111171","article-title":"Type-2 muscle fiber atrophy is associated with sarcopenia in elderly men with hip fracture","volume":"144","author":"Tanganelli","year":"2021","journal-title":"Exp. Gerontol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s10072-018-3505-0","article-title":"Muscle profile and cognition in patients with Alzheimer\u2019s disease dementia","volume":"39","author":"Moon","year":"2018","journal-title":"Neurol. Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/gps.4962","article-title":"Role of physical activity in ameliorating neuropsychiatric symptoms in Alzheimer disease: A narrative review","volume":"34","author":"Veronese","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.mayocp.2016.04.024","article-title":"Physical Activity and Alzheimer Disease: A Protective Association","volume":"91","author":"Emanuele","year":"2016","journal-title":"Mayo Clin. Proc."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M17-1528","article-title":"Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia: A Systematic Review","volume":"168","author":"Brasure","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.arr.2018.10.002","article-title":"Exercise-induced brain-derived neurotrophic factor expression: Therapeutic implications for Alzheimer\u2019s dementia","volume":"48","author":"Wang","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.physbeh.2019.01.018","article-title":"Exercise, ageing and cognitive function\u2014Effects of a personalized physical exercise program in the cognitive function of older adults","volume":"202","author":"Pereira","year":"2019","journal-title":"Physiol. Behav."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Polito, R., Di Meo, I., Barbieri, M., Daniele, A., Paolisso, G., and Rizzo, M.R. (2020). Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21239255"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1212\/WNL.51.5.1386","article-title":"Appendicular skeletal muscle mass, physical activity, and cognitive status in patients with Alzheimer\u2019s disease","volume":"51","author":"Dvorak","year":"1998","journal-title":"Neurology"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Wang, Y., Liu, Q., Quan, H., Kang, S.G., Huang, K., and Tong, T. (2021). Nutraceuticals in the Prevention and Treatment of the Muscle Atrophy. Nutrients, 13.","DOI":"10.3390\/nu13061914"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Thomas, J., Thomas, C.J., Radcliffe, J., and Itsiopoulos, C. (2015). Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer\u2019s Disease. Biomed. Res. Int., 2015.","DOI":"10.1155\/2015\/172801"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-220556","article-title":"Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer\u2019s Disease","volume":"90","author":"Nolan","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1533317520907168","DOI":"10.1177\/1533317520907168","article-title":"Nutritional and Functional Indicators and Their Association With Mortality Among Older Adults With Alzheimer\u2019s Disease","volume":"35","author":"Mendes","year":"2020","journal-title":"Am. J. Alzheimers Dis. Other Dement."},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Feraco, P., Gagliardo, C., La Tona, G., Bruno, E., D\u2019Angelo, C., Marrale, M., Del Poggio, A., Malaguti, M.C., Geraci, L., and Baschi, R. (2021). Imaging of Substantia Nigra in Parkinson\u2019s Disease: A Narrative Review. Brain Sci., 11.","DOI":"10.3390\/brainsci11060769"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-neuro-100720-034518","article-title":"Parkinson\u2019s Disease Genetics and Pathophysiology","volume":"44","author":"Zoghbi","year":"2021","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/1871527320666211006142100","article-title":"Tremor and Rigidity in Patients with Parkinson\u2019s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors","volume":"21","author":"Kumar","year":"2022","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","article-title":"Recent advances in the genetics of Parkinson\u2019s disease","volume":"12","author":"Martin","year":"2011","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Angelopoulou, E., Bougea, A., Papageorgiou, S.G., and Villa, C. (2022). Psychosis in Parkinson\u2019s Disease: A Lesson from Genetics. Genes, 13.","DOI":"10.3390\/genes13061099"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s13760-020-01473-5","article-title":"Genetics of Parkinson\u2019s disease","volume":"120","author":"Cherian","year":"2020","journal-title":"Acta Neurol. Belg."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/WCO.0000000000001167","article-title":"Parkinson\u2019s disease\u2014Genetic cause","volume":"36","author":"Ajith","year":"2023","journal-title":"Curr. Opin. Neurol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-021-00273-9","article-title":"Lewy body disease or diseases with Lewy bodies?","volume":"8","author":"Colosimo","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia","volume":"120","year":"2010","journal-title":"Acta Neuropathol."},{"key":"ref_182","first-page":"276","article-title":"The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson\u2019s disease","volume":"79","author":"Lenkiewicz","year":"2019","journal-title":"Acta Neurobiol. Exp."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Zhang, G., Xia, Y., Wan, F., Ma, K., Guo, X., Kou, L., Yin, S., Han, C., Liu, L., and Huang, J. (2018). New Perspectives on Roles of Alpha-Synuclein in Parkinson\u2019s Disease. Front. Aging Neurosci., 10.","DOI":"10.3389\/fnagi.2018.00370"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","article-title":"Mitochondrial Dysfunction and Parkinson\u2019s Disease: Pathogenesis and Therapeutic Strategies","volume":"48","author":"Nasrolahi","year":"2023","journal-title":"Neurochem. Res."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2023.05.007","article-title":"Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease, and Parkinson\u2019s disease, Huntington\u2019s disease and Amyotrophic Lateral Sclerosis\u2014An updated review","volume":"71","author":"Alqahtani","year":"2023","journal-title":"Mitochondrion"},{"key":"ref_186","first-page":"9163040","article-title":"The Sources of Reactive Oxygen Species and Its Possible Role in the Pathogenesis of Parkinson\u2019s Disease","volume":"2018","author":"Weng","year":"2018","journal-title":"Park. Dis."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2013.07.085","article-title":"The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson\u2019s disease","volume":"532","author":"Zuo","year":"2013","journal-title":"Gene"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1389202914666131210205839","article-title":"Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson\u2019s Disease","volume":"14","author":"Oczkowska","year":"2013","journal-title":"Curr. Genom."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson\u2019s Disease: Recent Advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci. Bull."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1042\/EBC20170023","article-title":"Autophagy impairment in Parkinson\u2019s disease","volume":"61","author":"Karabiyik","year":"2017","journal-title":"Essays Biochem."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson\u2019s Disease","volume":"432","author":"Hou","year":"2020","journal-title":"J. Mol. Biol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1007\/s12035-022-02851-1","article-title":"Exploring the Role of Ubiquitin-Proteasome System in Parkinson\u2019s Disease","volume":"59","author":"Behl","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12017-023-08755-0","article-title":"The Role of Ubiquitin-Proteasome System and Mitophagy in the Pathogenesis of Parkinson\u2019s Disease","volume":"25","author":"Liang","year":"2023","journal-title":"Neuromol. Med."},{"key":"ref_194","doi-asserted-by":"crossref","unstructured":"Troncoso-Escudero, P., Parra, A., Nassif, M., and Vidal, R.L. (2018). Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson\u2019s Disease. Front. Neurol., 9.","DOI":"10.3389\/fneur.2018.00860"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12272-019-01133-0","article-title":"Significant roles of neuroinflammation in Parkinson\u2019s disease: Therapeutic targets for PD prevention","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1016\/j.neuropharm.2012.01.028","article-title":"Contributions of central and systemic inflammation to the pathophysiology of Parkinson\u2019s disease","volume":"62","author":"Collins","year":"2012","journal-title":"Neuropharmacology"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/brain\/awy265","article-title":"Early microglial activation and peripheral inflammation in dementia with Lewy bodies","volume":"141","author":"Surendranathan","year":"2018","journal-title":"Brain"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.2174\/1570159X16666180222165418","article-title":"The Role of LRRK2 in Neurodegeneration of Parkinson Disease","volume":"16","author":"Rui","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/BST20180462","article-title":"LRRK2 links genetic and sporadic Parkinson\u2019s disease","volume":"47","author":"Kluss","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41582-019-0301-2","article-title":"LRRK2 in Parkinson disease: Challenges of clinical trials","volume":"16","author":"Tolosa","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Lavin, K.M., Ge, Y., Sealfon, S.C., Nair, V.D., Wilk, K., McAdam, J.S., Windham, S.T., Kumar, P.L., McDonald, M.N., and Bamman, M.M. (2020). Rehabilitative Impact of Exercise Training on Human Skeletal Muscle Transcriptional Programs in Parkinson\u2019s Disease. Front. Physiol., 11.","DOI":"10.3389\/fphys.2020.00653"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/B978-0-444-53491-0.00021-3","article-title":"Autonomic dysfunction in Parkinson disease","volume":"117","author":"Kaufmann","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.parkreldis.2009.06.003","article-title":"Histopathological analysis of skeletal muscle in patients with Parkinson\u2019s disease and \u2018dropped head\u2019\/\u2019bent spine\u2019 syndrome","volume":"15","author":"Gdynia","year":"2009","journal-title":"Park. Relat. Disord."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/NPT.0000000000000421","article-title":"Muscle Strength and Power in People With Parkinson Disease: A Systematic Review and Meta-analysis","volume":"47","author":"Gamborg","year":"2023","journal-title":"J. Neurol. Phys. Ther."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1212\/WNL.45.11.2097","article-title":"Generalized mitochondrial dysfunction in Parkinson\u2019s disease detected by magnetic resonance spectroscopy of muscle","volume":"45","author":"Penn","year":"1995","journal-title":"Neurology"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bbadis.2008.11.007","article-title":"Mitochondrial dysfunction in the limelight of Parkinson\u2019s disease pathogenesis","volume":"1792","author":"Banerjee","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00019052-199408000-00010","article-title":"Mitochondrial dysfunction in movement disorders","volume":"7","author":"Schulz","year":"1994","journal-title":"Curr. Opin. Neurol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/jcsm.13123","article-title":"\u03b1-Synuclein aggregation causes muscle atrophy through neuromuscular junction degeneration","volume":"14","author":"Yang","year":"2023","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Huang, Z., Chen, Y., and Zhang, Y. (2020). Mitochondrial reactive oxygen species cause major oxidative mitochondrial DNA damages and repair pathways. J. Biosci., 45.","DOI":"10.1007\/s12038-020-00055-0"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/01616412.2016.1251711","article-title":"Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders","volume":"39","author":"Islam","year":"2017","journal-title":"Neurol. Res."},{"key":"ref_212","first-page":"13","article-title":"PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson\u2019s Disease Pathobiology?","volume":"7","author":"Truban","year":"2017","journal-title":"J. Park. Dis."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"10249","DOI":"10.1523\/JNEUROSCI.1917-11.2011","article-title":"Parkin interacts with Ambra1 to induce mitophagy","volume":"31","author":"Cornelissen","year":"2011","journal-title":"J. Neurosci."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s11064-022-03586-0","article-title":"Distribution of \u03b1-Synuclein Aggregation in the Peripheral Tissues","volume":"47","author":"Li","year":"2022","journal-title":"Neurochem. Res."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"5379","DOI":"10.1007\/s12035-022-02897-1","article-title":"Role of Ubiquitin-Proteasome and Autophagy-Lysosome Pathways in \u03b1-Synuclein Aggregate Clearance","volume":"59","author":"Sahoo","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41418-020-00667-x","article-title":"Ubiquitin signaling in neurodegenerative diseases: An autophagy and proteasome perspective","volume":"28","author":"Youle","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Sala, G., Marinig, D., Arosio, A., and Ferrarese, C. (2016). Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson\u2019s Disease. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00157"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Basellini, M.J., Kothuis, J.M., Comincini, A., Pezzoli, G., Cappelletti, G., and Mazzetti, S. (2023). Pathological Pathways and Alpha-Synuclein in Parkinson\u2019s Disease: A View from the Periphery. Front. Biosci., 28.","DOI":"10.31083\/j.fbl2802033"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/NEN.0b013e3182801cde","article-title":"Alpha-synuclein pathology and axonal degeneration of the peripheral motor nerves innervating pharyngeal muscles in Parkinson disease","volume":"72","author":"Mu","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/1073858421991066","article-title":"Neuroinflammation in Parkinson\u2019s Disease: Triggers, Mechanisms, and Immunotherapies","volume":"28","author":"Wang","year":"2022","journal-title":"Neuroscientist"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","article-title":"Role of neuroinflammation in neurodegeneration development","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cns.13282","article-title":"Activated Schwann cells and increased inflammatory cytokines IL-1\u03b2, IL-6, and TNF-\u03b1 in patients\u2019 sural nerve are lack of tight relationship with specific sensory disturbances in Parkinson\u2019s disease","volume":"26","author":"Zhang","year":"2020","journal-title":"CNS Neurosci. Ther."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.arr.2014.11.003","article-title":"DAMPs and neurodegeneration","volume":"24","author":"Thundyil","year":"2015","journal-title":"Ageing Res. Rev."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Moehlman, A.T., Kanfer, G., and Youle, R.J. (2023). Loss of STING in parkin mutant flies suppresses muscle defects and mitochondria damage. PLoS Genet., 19.","DOI":"10.1371\/journal.pgen.1010828"},{"key":"ref_227","doi-asserted-by":"crossref","unstructured":"Ji, Y., Li, M., Chang, M., Liu, R., Qiu, J., Wang, K., Deng, C., Shen, Y., Zhu, J., and Wang, W. (2022). Inflammation: Roles in Skeletal Muscle Atrophy. Antioxidants, 11.","DOI":"10.3390\/antiox11091686"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40263-013-0124-4","article-title":"Mitochondrial enhancement for neurodegenerative movement disorders: A systematic review of trials involving creatine, coenzyme Q10, idebenone and mitoquinone","volume":"28","author":"Liu","year":"2014","journal-title":"CNS Drugs"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson\u2019s and Huntington\u2019s diseases","volume":"109","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2741\/4231","article-title":"Clinical applications of coenzyme Q10","volume":"19","author":"Cordero","year":"2014","journal-title":"Front. Biosci."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/1541-4337.12539","article-title":"Coenzyme Q10 supplementation: Efficacy, safety, and formulation challenges","volume":"19","year":"2020","journal-title":"Compr. Rev. Food Sci. Food Saf."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jnutbio.2019.02.012","article-title":"N-acetylcysteine and alpha-lipoic acid improve antioxidant defenses and decrease oxidative stress, inflammation and serum lipid levels in ovariectomized rats via estrogen-independent mechanisms","volume":"67","author":"Delgobo","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Ciulla, M., Marinelli, L., Cacciatore, I., and Stefano, A.D. (2019). Role of Dietary Supplements in the Management of Parkinson\u2019s Disease. Biomolecules, 9.","DOI":"10.3390\/biom9070271"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10787-023-01192-2","article-title":"A story of the potential effect of non-steroidal anti-inflammatory drugs (NSAIDs) in Parkinson\u2019s disease: Beneficial or detrimental effects","volume":"31","author":"Alrouji","year":"2023","journal-title":"Inflammopharmacology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2174\/1567205054367883","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease","volume":"2","author":"Klegeris","year":"2005","journal-title":"Curr. Alzheimer Res."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Four\u00e9, A., and Bendahan, D. (2017). Is Branched-Chain Amino Acids Supplementation an Efficient Nutritional Strategy to Alleviate Skeletal Muscle Damage? A Systematic Review. Nutrients, 9.","DOI":"10.3390\/nu9101047"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-physiol-020518-114455","article-title":"Branched Chain Amino Acids","volume":"81","author":"Neinast","year":"2019","journal-title":"Annu. Rev. Physiol."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"529s","DOI":"10.1093\/jn\/136.2.529S","article-title":"Nutraceutical effects of branched-chain amino acids on skeletal muscle","volume":"136","author":"Shimomura","year":"2006","journal-title":"J. Nutr."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12970-017-0184-9","article-title":"Branched-chain amino acids and muscle protein synthesis in humans: Myth or reality?","volume":"14","author":"Wolfe","year":"2017","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1038\/s41467-020-16886-2","article-title":"Leucine regulates autophagy via acetylation of the mTORC1 component raptor","volume":"11","author":"Son","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbi.2022.09.009","article-title":"Role of gut microbiota-derived branched-chain amino acids in the pathogenesis of Parkinson\u2019s disease: An animal study","volume":"106","author":"Yan","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jns.2016.05.056","article-title":"Biochemical and clinical effects of Whey protein supplementation in Parkinson\u2019s disease: A pilot study","volume":"367","author":"Tosukhowong","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-009-1364-1","article-title":"Brain-derived neurotrophic factor is produced by skeletal muscle cells in response to contraction and enhances fat oxidation via activation of AMP-activated protein kinase","volume":"52","author":"Matthews","year":"2009","journal-title":"Diabetologia"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Krumpolec, P., Vallova, S., Slobodova, L., Tirpakova, V., Vajda, M., Schon, M., Klepochova, R., Janakova, Z., Straka, I., and Sutovsky, S. (2017). Aerobic-Strength Exercise Improves Metabolism and Clinical State in Parkinson\u2019s Disease Patients. Front. Neurol., 8.","DOI":"10.3389\/fneur.2017.00698"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s13311-020-00904-8","article-title":"Current Perspectives on Aerobic Exercise in People with Parkinson\u2019s Disease","volume":"17","author":"Schootemeijer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"ref_246","first-page":"21","article-title":"Effects of endurance exercise training on the motor and non-motor features of Parkinson\u2019s disease: A review","volume":"5","author":"Lamotte","year":"2015","journal-title":"J. Park. Dis."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"104422","DOI":"10.1016\/j.archger.2021.104422","article-title":"Effect of aerobic exercise on functional capacity and quality of life in individuals with Parkinson\u2019s disease: A systematic review of randomized controlled trials","volume":"95","author":"Lobato","year":"2021","journal-title":"Arch. Gerontol. Geriatr."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Supriya, R., Singh, K.P., Gao, Y., Gu, Y., and Baker, J.S. (2021). Effect of Exercise on Secondary Sarcopenia: A Comprehensive Literature Review. Biology, 11.","DOI":"10.3390\/biology11010051"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/japplphysiol.00557.2016","article-title":"Resistance training with instability is more effective than resistance training in improving spinal inhibitory mechanisms in Parkinson\u2019s disease","volume":"122","author":"Mattos","year":"2017","journal-title":"J. Appl. Physiol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.gaitpost.2017.12.027","article-title":"Balance and fear of falling in subjects with Parkinson\u2019s disease is improved after exercises with motor complexity","volume":"61","author":"Corcos","year":"2018","journal-title":"Gait Posture"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.smhs.2020.05.005","article-title":"Hatha yoga training improves standing balance but not gait in Parkinson\u2019s disease","volume":"2","author":"Elangovan","year":"2020","journal-title":"Sports Med. Health Sci."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"117345","DOI":"10.1016\/j.lfs.2020.117345","article-title":"The benefits and mechanisms of exercise training for Parkinson\u2019s disease","volume":"245","author":"Feng","year":"2020","journal-title":"Life Sci."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1519\/JPT.0b013e3182abe784","article-title":"Impact of Tai Chi Chu\u2019an practice on balance and mobility in older adults: An integrative review of 20 years of research","volume":"37","author":"Hackney","year":"2014","journal-title":"J. Geriatr. Phys. Ther."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s42466-021-00162-9","article-title":"Therapy development for spinal muscular atrophy: Perspectives for muscular dystrophies and neurodegenerative disorders","volume":"4","author":"Jablonka","year":"2022","journal-title":"Neurol. Res. Pract."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1096\/fj.06-6604com","article-title":"Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases","volume":"21","author":"Sacheck","year":"2007","journal-title":"FASEB J."},{"key":"ref_256","first-page":"1185","article-title":"ALS and other motor neuron diseases","volume":"20","author":"Tiryaki","year":"2014","journal-title":"Continuum"},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/1353-8020(95)00004-P","article-title":"Neurodegenerative \u2018overlap\u2019 syndrome: Clinical and pathological features of Parkinson\u2019s disease, motor neuron disease, and Alzheimer\u2019s disease","volume":"1","author":"Uitti","year":"1995","journal-title":"Park. Relat. Disord."},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.112.192138","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"342","author":"Johri","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3233\/JAD-2009-0972","article-title":"An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer\u2019s disease","volume":"16","author":"Moreira","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/sj.cdd.4402160","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease","volume":"14","author":"Schapira","year":"2007","journal-title":"Cell Death Differ."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2119\/2007-00100.Irvine","article-title":"Protein aggregation in the brain: The molecular basis for Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"14","author":"Irvine","year":"2008","journal-title":"Mol. Med."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.4103\/1673-5374.386406","article-title":"Amyloid-beta and tau protein beyond Alzheimer\u2019s disease","volume":"19","author":"Abyadeh","year":"2024","journal-title":"Neural Regen. Res."},{"key":"ref_263","doi-asserted-by":"crossref","unstructured":"Khan, M.S.H., and Hegde, V. (2020). Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer\u2019s Disease. J. Pers. Med., 10.","DOI":"10.3390\/jpm10020042"},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"999","DOI":"10.2174\/1381612053381620","article-title":"Inflammatory process in Parkinson\u2019s disease: Role for cytokines","volume":"11","author":"Nagatsu","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.1016\/S1353-8020(11)70064-5","article-title":"Neurodegeneration and inflammation in Parkinson\u2019s disease","volume":"18","author":"Phani","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4196\/kjpp.2012.16.5.305","article-title":"Effects of Treadmill Exercise on the Recovery of Dopaminergic Neuron Loss and Muscle Atrophy in the 6-OHDA Lesioned Parkinson\u2019s Disease Rat Model","volume":"16","author":"Choe","year":"2012","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/ern.11.57","article-title":"Loss of motor function in preclinical Alzheimer\u2019s disease","volume":"11","author":"Buchman","year":"2011","journal-title":"Expert. Rev. Neurother."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"e13630","DOI":"10.1111\/apha.13630","article-title":"The key role of physical activity against the neuromuscular deterioration in patients with Parkinson\u2019s disease","volume":"231","author":"Martignon","year":"2021","journal-title":"Acta Physiol."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neubiorev.2017.04.030","article-title":"The effects of aging in the hippocampus and cognitive decline","volume":"79","author":"Bettio","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1600-0404.2010.01412.x","article-title":"Physical exercise alleviates debilities of normal aging and Alzheimer\u2019s disease","volume":"123","author":"Archer","year":"2011","journal-title":"Acta Neurol. Scand."},{"key":"ref_271","doi-asserted-by":"crossref","unstructured":"Tsitkanou, S., Della Gatta, P., Foletta, V., and Russell, A. (2019). The Role of Exercise as a Non-pharmacological Therapeutic Approach for Amyotrophic Lateral Sclerosis: Beneficial or Detrimental?. Front. Neurol., 10.","DOI":"10.3389\/fneur.2019.00783"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"61","DOI":"10.31887\/DCNS.2019.21.1\/nlautenschlager","article-title":"Physical activity for cognitive health: What advice can we give to older adults with subjective cognitive decline and mild cognitive impairment?","volume":"21","author":"Lautenschlager","year":"2019","journal-title":"Dialogues Clin. Neurosci."},{"key":"ref_273","doi-asserted-by":"crossref","unstructured":"Pham, J., Keon, M., Brennan, S., and Saksena, N. (2020). Connecting RNA-Modifying Similarities of TDP-43, FUS, and SOD1 with MicroRNA Dysregulation Amidst A Renewed Network Perspective of Amyotrophic Lateral Sclerosis Proteinopathy. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103464"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"154454","DOI":"10.1016\/j.metabol.2020.154454","article-title":"Functions of amyloid precursor protein in metabolic diseases","volume":"115","author":"Guo","year":"2021","journal-title":"Metabolism"},{"key":"ref_275","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tibs.2017.09.002","article-title":"The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy","volume":"42","author":"Kwon","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1179\/1743132813Y.0000000288","article-title":"Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer\u2019s disease","volume":"36","author":"Hong","year":"2014","journal-title":"Neurol. Res."},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nn.2575","article-title":"Autophagy gone awry in neurodegenerative diseases","volume":"13","author":"Wong","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1038\/emm.2014.117","article-title":"Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies","volume":"47","author":"Ciechanover","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/187152710793237421","article-title":"Autophagy in the central nervous system: Implications for neurodegenerative disorders","volume":"9","author":"Xilouri","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"15194","DOI":"10.1074\/jbc.M113.457408","article-title":"Lewy body-like \u03b1-synuclein aggregates resist degradation and impair macroautophagy","volume":"288","author":"Tanik","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised autophagy and neurodegenerative diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/9\/719\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:54:56Z","timestamp":1760111696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/13\/9\/719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":282,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["biology13090719"],"URL":"https:\/\/doi.org\/10.3390\/biology13090719","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]}}}